Tilray Wins Authorization to Sell Medical Marijuana in Portugal
Tilray (NASDAQ: TLRY) has opened a new market for its medical marijuana. The company announced Monday that Portugal's national healthcare regulator, Infarmed, has granted it authorization to sell its products in that country.
"This is the first time a full quality dossier was required and delivered to obtain market authorization in Europe for a medical cannabis product," Tilray wrote in the press release trumpeting the news.
Such authorization is fairly restrictive, however. It permits Tilray's medical marijuana to be prescribed only for a limited number of uses, such as to treat spasticity related to multiple sclerosis or spinal cord damage, and nausea and vomiting resulting from medical treatments such as chemotherapy.
Source Fool.com
